ROLE OF C-REACTIVE PROTEIN AS A MARKER FOR MICROALBUMINURIA IN TYPE 2 DIABETICS
AbstractBackground: One of the most important complications of Type 2 diabetes mellitus is diabetic nephropathy which is reported as the leading cause of premature deaths due to renal failure. This study was being conducted to see the role of C-reactive protein a marker in type 2 diabetic patient with micro-albuminuria. Methods: This cross sectional study was carried out in the Diabetic Clinic of Pakistan Medical Research Council, Research Centre Lahore. Personal history about the disease was collected on a questionnaire. Blood and urine sample of 50 type 2 diabetic patients between the ages of 40–65 years were collected to analyze C-reactive protein and micro-albuminuria respectively. Data were analyzed using SPSS-15. The Pearson correlation coefficient test was used to determine correlation between urine albumin and C-reactive protein. Results: There were 22 micro-albuminuria positive cases out of total 50 diabetic cases. Of these14 (63%) showed raised C-reactive protein levels (p<0.00). Conclusion: There is significant association between the level of serum C-reactive proteins and micro-albuminuria in type 2 diabetics Keywords: CRP, Micro-albuminuria, Type 2 Diabetes
Power AC. Diabetes Mellitus. In: Jameson JL, editor. Harrison’s Endocrinology. 1st ed. New York: McGraw-Hill; 2006.p. 303–4.
Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann NY Acad Sci 2006;1084:1–29.
WHO. Diabetes facts 2006. Fact sheet 312. WHO 2013. Available at: http://www.who.int/mediacentre/ factsheets/fs312/en/
Marshall WJ, Bangert SK, editors. Clinical Chemistry. 5th ed. London: Elsevier; 2004.
Burtis CA, Ashwood ER, Bruns DE, editors. Teitz Textbook of Clinical Chemistry and Molecular Diagnosis. 4th ed. New Delhi: Elsevier; 2006.
American Diabetes Association. Nephropathy in diabetes (Position Statement). Diabetes Care 2004;27(Supple 1):S79–83.
de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, et al. Central obesity, incident microalbuminuria and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007;18:235–43.
Festa A, D’Agostino R , Howard G, Mykkanen L. Tracy RP, Haffiner SM. Inflammation and microalbbuminuria in non diabetic and type 2 diabetic subjects; The insulin Reisistance Atherosclerosis study. Kidney Int 2000;58:1703–10.
Brownlee M, Aiello LP, Friedman E, Vinik AI, Nesto Rw, Boulton AJ. Complications of diabetes mellitus. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Endocrinology. 10th ed. Philadelphia: WB Saunders, 2003; p.1509–40.
Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, shakeri MT, Aiatollahi H. Elevated serum C reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Iran J Kidney Dis 2009;3(1):12–6.
Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, Shoham DA, et al. Association of C reactive protein and microalbuminuria (from the National Health and Nutrition examination surveys, 1999 to 2004). Am J Cardiol 2008;101:401–6.
Huffman G. F, Whisner S, Zarini G. G, Nath S. Waist Circumference and BMI in relation to serum high sensitivity C reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes. Int J Environ Res Public Health 2010;7:842–52.
Rehman K, Hashim R, Anwar M.S, Qureshi A, Khursheed M. Type 2 diabetes and its association with hypertension and high urinary albumin excretion. Pak J Med Res 2004;43(4):153–6.
Stuveling EM, Hillege HL, Bakker SJ, Gans RO, Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003;63:654–61.
Alzaid AA. Microalbuminuria in patients with NIDDM: An overview. Diabetes Care 1996;19:79–89.
Gall M A, Hougaard P, Borch-Johnsen K, Parving H H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus, BMJ 1997;314(7083):783–8.
Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439–41.
Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low grade inflammation in type 2 diabetes. Diabetes 2002;51:1157–65.
Weiss MF, Rodby RA, Justice AC, Hricik DE. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Kidney Int 1998;54:193–202.